In the largest genetic study of inflammatory bowel disease (IBD) traits to date, researchers have identified a genetic marker associated with more severe ulcerative colitis and Crohn's disease—the ...

This week's notable citations: Astronomers believe collapsing stars could spawn mini universes. Chimpanzees do not like unfairness. And a single dose of psilocybin temporarily restored function in an ...

The stigma of the condition and the mental health ramifications, as well as invasive testing and increased risks of certain cancers, all place extra burdens on these patients. (Marcelo Ricardo ...

CLF065, a long-acting, once-weekly GLP-2 receptor agonist, advances in two inflammatory bowel disease indications. The studies aim to bring a regenerative treatment option to patients living with IBD, ...

Neutralizing autoantibodies against interleukin-10 can result in a phenocopy of monogenic defects of interleukin-10 signaling in children and may be associated with inflammatory bowel disease (IBD).

Add Yahoo as a preferred source to see more of our stories on Google. Karen Read, the Mansfield woman acquitted of murder last year in the death of her Boston police officer boyfriend, has filed a new ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Representative Thomas Massie has promised to identify more individuals ...

WASHINGTON—Most applicants for green cards will need to go abroad to apply for permanent residency at an American Consulate, rather than filing from within the U.S. as they do now, the Trump ...

Ben Relles' Make Believe counts Reid Hoffman as an investor, and is developing tech to enable entertainment that talks back to viewers. By Alex Weprin Senior Editor A YouTuber-turned tech executive is ...

SpaceX confirmed plans to sell shares of its stock to the public for the first time, according to a securities filing Wednesday outlining the company’s fundamentals. Limited time: Save 25% on NBC News ...

SpaceX revealed its long-awaited plans to go public on Wednesday, shedding light on the finances and leadership of one of the largest, best-known and yet most secretive private companies in history.

New York State’s Office of Cannabis Management (OCM) announced Thursday that it will lead a new clinical study on the effects of CBD and THC on patients living with inflammatory bowel disease (IBD).